laboratory specialized in the treatment of rare neurological diseases

« Rare neurological disorders, a major societal challenge and a market in crucial need of therapeutic innovation »

> Governance

Franck MOUTHON - Theranexus, Chairman and CEO
Franck MOUTHON
Theranexus, Chairman and CEO
 
Mathieu CHARVÉRIAT - Theranexus, Deputy CEO
Mathieu CHARVÉRIAT
Theranexus, Deputy CEO
  
Rodolphe BESSERVE - Independent director
Rodolphe BESSERVE
Independent director
 
Jérôme MARTINEZ - Independent director
Jérôme MARTINEZ
Independent director
 

Auriga, represented
by Sébastien Descarpentries
 

Eric DOULAT - Independent director
Eric DOULAT
Independent director